1-11 of 11
Lisa H. Butterfield
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

James S. Wilmott, Hussein Tawbi, Johnathan A. Engh, Nduka M. Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A. Vergara, Hansol Lee, Peter A. Johansson, Peter M. Ferguson, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Lisa H. Butterfield, Richard A. Scolyer, John M. Kirkwood, Georgina V. Long, Michael A. Davies
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (3): 521–531.
https://doi.org/10.1158/1078-0432.CCR-22-2581
Published: 01 February 2023
View article titled, Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
Open the PDF for Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases in another window
Includes: Supplementary data
Journal Articles

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

Yana G. Najjar, Dustin McCurry, Huang Lin, Yan Lin, Yan Zang, Diwakar Davar, Arivarasan Karunamurthy, Joseph J. Drabick, Rogerio I. Neves, Lisa H. Butterfield, Marc S. Ernstoff, Igor Puzanov, Joseph J. Skitzki, Jennifer Bordeaux, IlaSri B. Summit, Jehovana O. Bender, Ju Young Kim, Beiru Chen, Ghanashyam Sarikonda, Anil Pahuja, Jennifer Tsau, Zeni Alfonso, Christian Laing, James F. Pingpank, Matthew P. Holtzman, Cindy Sander, Amy Rose, Hassane M. Zarour, John M. Kirkwood, Ahmad A. Tarhini
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4195–4204.
https://doi.org/10.1158/1078-0432.CCR-20-4301
Published: 01 August 2021
View article titled, Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Open the PDF for Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)

Lisa H. Butterfield, Fengmin Zhao, Sandra Lee, Ahmad A. Tarhini, Kim A. Margolin, Richard L. White, Michael B. Atkins, Gary I. Cohen, Theresa L. Whiteside, John M. Kirkwood, David H. Lawson
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5034–5043.
https://doi.org/10.1158/1078-0432.CCR-16-3016
Published: 31 August 2017
View article titled, Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
Open the PDF for Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697) in another window
Includes: Supplementary data
Journal Articles

Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

Hideho Okada, Lisa H. Butterfield, Ronald L. Hamilton, Aki Hoji, Masashi Sakaki, Brian J. Ahn, Gary Kohanbash, Jan Drappatz, Johnathan Engh, Nduka Amankulor, Mark O. Lively, Michael D. Chan, Andres M. Salazar, Edward G. Shaw, Douglas M. Potter, Frank S. Lieberman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 286–294.
https://doi.org/10.1158/1078-0432.CCR-14-1790
Published: 14 January 2015
View article titled, Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
Open the PDF for Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC in another window
Includes: Supplementary data
Journal Articles

Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer

Patrick J. Schuler, Malgorzata Harasymczuk, Carmen Visus, Albert DeLeo, Sumita Trivedi, Yu Lei, Athanassios Argiris, William Gooding, Lisa H. Butterfield, Theresa L. Whiteside, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2433–2444.
https://doi.org/10.1158/1078-0432.CCR-13-2617
Published: 30 April 2014
View article titled, Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Open the PDF for Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

Craig L. Slingluff, Jr, Sandra Lee, Fengmin Zhao, Kimberly A. Chianese-Bullock, Walter C. Olson, Lisa H. Butterfield, Theresa L. Whiteside, Philip D. Leming, John M. Kirkwood
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (15): 4228–4238.
https://doi.org/10.1158/1078-0432.CCR-13-0002
Published: 31 July 2013
View article titled, A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
Open the PDF for A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602) in another window
Includes: Supplementary data
Journal Articles

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Lisa H. Butterfield, A. Karolina Palucka, Cedrik M. Britten, Madhav V. Dhodapkar, Leif Håkansson, Sylvia Janetzki, Yutaka Kawakami, Thomas-Oliver Kleen, Peter P. Lee, Cristina Maccalli, Holden T. Maecker, Vernon C. Maino, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Graham Pawelec, Douglas M. Potter, Licia Rivoltini, Lupe G. Salazar, Dolores J. Schendel, Craig L. Slingluff, Jr, Wenru Song, David F. Stroncek, Hideaki Tahara, Magdalena Thurin, Giorgio Trinchieri, Sjoerd H. van Der Burg, Theresa L. Whiteside, Jon M. Wigginton, Francesco Marincola, Samir Khleif, Bernard A. Fox, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3064–3076.
https://doi.org/10.1158/1078-0432.CCR-10-2234
Published: 15 May 2011
View article titled, Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Open the PDF for Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers in another window
Journal Articles

Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696

John M. Kirkwood, Sandra Lee, Stergios J. Moschos, Mark R. Albertini, John C. Michalak, Cindy Sander, Theresa Whiteside, Lisa H. Butterfield, Louis Weiner
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1443–1451.
https://doi.org/10.1158/1078-0432.CCR-08-1231
Published: 19 February 2009
View article titled, Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
Open the PDF for Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696 in another window
Journal Articles

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

Lisa H. Butterfield, Antoni Ribas, Vivian B. Dissette, Yohan Lee, Jin Quan Yang, Pilar De la Rocha, Sonia D. Duran, Jackie Hernandez, Elisabeth Seja, Douglas M. Potter, William H. McBride, Richard Finn, John A. Glaspy, James S. Economou
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2817–2825.
https://doi.org/10.1158/1078-0432.CCR-05-2856
Published: 04 May 2006
View article titled, A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides
Open the PDF for A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides in another window
Journal Articles

T-Cell Responses to HLA-A*0201 Immunodominant Peptides Derived from α-Fetoprotein in Patients with Hepatocellular Cancer

Lisa H. Butterfield, Antoni Ribas, Wilson S. Meng, Vivian B. Dissette, Saral Amarnani, Huong T. Vu, Elisabeth Seja, Karen Todd, John A. Glaspy, William H. McBride, James S. Economou
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5902–5908.
Published: 15 December 2003
View article titled, T-Cell Responses to HLA-A*0201 Immunodominant Peptides Derived from α-Fetoprotein in Patients with Hepatocellular Cancer
Open the PDF for T-Cell Responses to HLA-A*0201 Immunodominant Peptides Derived from α-Fetoprotein in Patients with Hepatocellular Cancer in another window
Journal Articles

Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma

Lisa H. Butterfield, Antoni Ribas, Vivian B. Dissette, Saral N. Amarnani, Huong T. Vu, Denise Oseguera, He-Jing Wang, Robert M. Elashoff, William H. McBride, Bijay Mukherji, Alistair J. Cochran, John A. Glaspy, James S. Economou
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (3): 998–1008.
Published: 01 March 2003
View article titled, Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma
Open the PDF for Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma in another window